Last reviewed · How we verify
Best Medical Management
Best Medical Management is a Small molecule drug developed by Beijing Tiantan Hospital. It is currently in Phase 3 development for Hypertension, Hyperlipidemia. Also known as: Best medical management group, No other intervention.
Best Medical Management is a treatment approach that focuses on managing a patient's condition through a combination of medications, lifestyle changes, and other interventions.
Best Medical Management is a treatment approach that focuses on managing a patient's condition through a combination of medications, lifestyle changes, and other interventions. Used for Hypertension, Hyperlipidemia.
At a glance
| Generic name | Best Medical Management |
|---|---|
| Also known as | Best medical management group, No other intervention |
| Sponsor | Beijing Tiantan Hospital |
| Modality | Small molecule |
| Therapeutic area | Cardiovascular |
| Phase | Phase 3 |
Mechanism of action
This approach typically involves a multidisciplinary team of healthcare professionals working together to develop a personalized treatment plan that takes into account the patient's medical history, current health status, and treatment goals. The goal of Best Medical Management is to improve the patient's quality of life and slow disease progression.
Approved indications
- Hypertension
- Hyperlipidemia
Common side effects
- Gastrointestinal side effects
- Musculoskeletal side effects
Key clinical trials
- Pragmatic Comparative Effectiveness Trial of Evidence-based, On-demand, Digital Behavioral Treatments for Chronic Pain (NA)
- Perioperative Telemonitoring to Optimize Cancer Care and Outcomes (NA)
- MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial) (PHASE2)
- Testing Pembrolizumab Versus Observation in Patients With Merkel Cell Carcinoma After Surgery, STAMP Trial (PHASE3)
- MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence (NA)
- Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity (PHASE2, PHASE3)
- A Financial Intervention (Financial Compass) to Identify and Address Financial Hardship Among Head and Neck Cancer Patients, Financial Compass Trial (NA)
- Home-based Respiratory Muscle Training for Minimizing Side Effects in Patients Undergoing Treatment for Breast Cancer (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Best Medical Management CI brief — competitive landscape report
- Best Medical Management updates RSS · CI watch RSS
- Beijing Tiantan Hospital portfolio CI
Frequently asked questions about Best Medical Management
What is Best Medical Management?
How does Best Medical Management work?
What is Best Medical Management used for?
Who makes Best Medical Management?
Is Best Medical Management also known as anything else?
What development phase is Best Medical Management in?
What are the side effects of Best Medical Management?
Related
- Manufacturer: Beijing Tiantan Hospital — full pipeline
- Therapeutic area: All drugs in Cardiovascular
- Indication: Drugs for Hypertension
- Indication: Drugs for Hyperlipidemia
- Also known as: Best medical management group, No other intervention
- Compare: Best Medical Management vs similar drugs
- Pricing: Best Medical Management cost, discount & access